•  
     
    Strategic Planning
    Strategic Planning

    Be a credible threat. As you seek funding, we create product development plans that align clinical and regulatory milestones with costs.

    Development Strategy Used for Fundraising

    Small virtual biotech start-up with stem-cell therapy treatment for HIV. Strong scientific expertise but limited experience in moving research phase work into early clinical (pre-IND) development.
  •  
     
    Due Diligence
    Due Diligence

    Know what you’re up against. We inform decision making on product acquisition strategies by identifying both regulatory and operational risks.

    Indication Selection

    A Life sciences venture capital firm come to Halloran looking for help prioritizing potential indications for their lead oncology compound.
  •  
     
    Road Mapping
    Road Mapping

    What is possible, and what is probable. We bring together KOL opinions, market assessments, and reality, so you can make the business decisions.

    Starting up a Life Science Division

    A mature, global animal health company wanted to expand into human healthcare.  The company was unsure whether their lead product was ready to advance to IND-enabling activities.  The company also lacked expertise in human clinical product development.

Meet the Plan team leads

Sheila Gwizdak
Vice President, Quality
Jason Milovanovic
Vice President, Clinical Development & Operations
Kim Raymer
Vice President, Regulatory Affairs
Kathrin Schalper, Ph.D.
Senior Principal Consultant, Regulatory Strategy
Greg Dombal
President, Chief Operating Officer
Katie McCarthy
Chief Development Officer, Managing Director